News
Lilly finally gets FDA OK for ulcerative colitis drug Omvoh
After an earlier rejection, the FDA has approved Eli Lilly’s first-in-class IL-23p19 inhibitor mirikizumab as a treatment for adults with moderately to severely active ulc
